| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samantha Johnstone, Maryam Sorkhou, Molly Zhang, Sarah S Dermody, Rachel A Rabin, Tony P Georg. Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies. The American journal of drug and alcohol abuse. 2024-01-12. PMID:38214479. |
cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies. |
2024-01-12 |
2024-01-14 |
Not clear |
| Hajar Rachid, Zineb Saif, Salma Raoui, Zineb Serhier, Mohamed Agou. Does cannabis affect cognitive functioning in patients with schizophrenia? Schizophrenia research. Cognition. vol 36. 2024-01-10. PMID:38196922. |
does cannabis affect cognitive functioning in patients with schizophrenia? |
2024-01-10 |
2024-01-13 |
human |
| Hajar Rachid, Zineb Saif, Salma Raoui, Zineb Serhier, Mohamed Agou. Does cannabis affect cognitive functioning in patients with schizophrenia? Schizophrenia research. Cognition. vol 36. 2024-01-10. PMID:38196922. |
the aim of this study was to evaluate the effects of cannabis use on cognitive function in moroccan patients with schizophrenia who were cannabis users. |
2024-01-10 |
2024-01-13 |
human |
| Gaurav Maggu, Swati Choudhary, Rajon Jaishy, Suprakash Chaudhury, Daniel Saldanha, Manish Boras. Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. Industrial psychiatry journal. vol 32. issue 2. 2024-01-01. PMID:38161465. |
cannabis use has been stated as a causal risk factor for the occurrence of schizophrenia and other psychotic disorders. |
2024-01-01 |
2024-01-05 |
Not clear |
| Nicolás Lamanna-Rama, Diego Romero-Miguel, Marta Casquero-Veiga, Karina S MacDowell, Cristina Santa-Marta, Sonia Torres-Sánchez, Esther Berrocoso, Juan C Leza, Manuel Desco, María Luisa Soto-Montenegr. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation. Psychiatry research. vol 331. 2023-12-08. PMID:38064909. |
prenatal infections and cannabis use during adolescence are well-recognized risk factors for schizophrenia. |
2023-12-08 |
2023-12-17 |
Not clear |
| Alberto Sainz-Cort, Marta Martín-Islas, Genís Oña, Daniel Jimenez-Garrido, Miriam López-Navarro, Elena Muñoz-Marron, Raquel Viejo-Sobera, Jose Carlos Bous. Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis. International clinical psychopharmacology. 2023-11-20. PMID:37982285. |
however, the understanding of the psychological effects of cannabis is still limited, and it has been previously linked to mental disorders such as schizophrenia. |
2023-11-20 |
2023-11-29 |
human |
| Valerio Ricci, Enrico Cristofori, Erica Passarello, Andrea Paggi, Alex Cavallo, Franca Ceci, Giovanni Martinotti, Domenico De Berardis, Giuseppe Main. CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE. Psychiatria Danubina. vol 35. issue 3. 2023-11-02. PMID:37917836. |
proof of correlation between psychotic spectrum disorders and suicide are found in literature, as well as between cannabis use disorder (cud) and suicide and between cud and schizophrenia. |
2023-11-02 |
2023-11-08 |
human |
| Valerio Ricci, Enrico Cristofori, Erica Passarello, Andrea Paggi, Alex Cavallo, Franca Ceci, Giovanni Martinotti, Domenico De Berardis, Giuseppe Main. CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE. Psychiatria Danubina. vol 35. issue 3. 2023-11-02. PMID:37917836. |
in conclusion, emerging data on the correlation between cannabis use and suicide risk in patients with schizophrenia or other schizophrenic spectrum disorders are insufficient to draw firm conclusions. |
2023-11-02 |
2023-11-08 |
human |
| Mario Moreno-Fernández, Marcos Ucha, Raquel Reis-de-Paiva, Alberto Marcos, Emilio Ambrosio, Alejandro Higuera-Mata. Lack of interactions between prenatal immune activation and Δ Progress in neuro-psychopharmacology & biological psychiatry. 2023-11-02. PMID:37918558. |
lack of interactions between prenatal immune activation and Δ the causality in the association between cannabis use and the risk of developing schizophrenia has been the subject of intense debate in the last few years. |
2023-11-02 |
2023-11-08 |
human |
| Valerio Ricci, Domenico de Berardis, Giovanni Martinotti, Giuseppe Main. Neurotrophic Factors In Cannabis-Induced Psychosis: An Update. Current topics in medicinal chemistry. 2023-08-30. PMID:37644743. |
exposure to cannabis can induce the development of psychosis and schizophrenia in vulnerable individuals. |
2023-08-30 |
2023-09-07 |
Not clear |
| Stav Bloch Priel, Assif Yitzhaky, David Gurwitz, Libi Hertzber. Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta-analysis. The European journal of neuroscience. 2023-08-23. PMID:37611908. |
cannabis use leads to symptom exacerbation in schizophrenia patients, and endocannabinoid ligands have been studied as tentative schizophrenia therapeutics. |
2023-08-23 |
2023-09-07 |
human |
| Shinnyi Chou, Kenneth N Fish, David A Lewis, Robert A Swee. Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study. Neurobiology of disease. 2023-08-16. PMID:37586566. |
individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. |
2023-08-16 |
2023-09-07 |
human |
| Jonathan Fridman, Esther Bloemhof-Bris, Shira Weizman, Tal Kessler, Dorit Porat, Amos Ivry, Aviva Wolf, Rafael Stryjer, Assaf Shele. Inflammation Markers Among Schizophrenia Patients Who Use Cannabis. Clinical neuropharmacology. 2023-06-19. PMID:37335845. |
inflammation markers among schizophrenia patients who use cannabis. |
2023-06-19 |
2023-08-14 |
Not clear |
| Jonathan Fridman, Esther Bloemhof-Bris, Shira Weizman, Tal Kessler, Dorit Porat, Amos Ivry, Aviva Wolf, Rafael Stryjer, Assaf Shele. Inflammation Markers Among Schizophrenia Patients Who Use Cannabis. Clinical neuropharmacology. 2023-06-19. PMID:37335845. |
this study examined the differences in the levels of nlr and mpv among schizophrenia patients with cannabis use versus those without. |
2023-06-19 |
2023-08-14 |
Not clear |
| Gianfranco Di Gennaro, Marco Colizz. Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example. Epidemiology and psychiatric sciences. vol 32. 2023-06-15. PMID:37317558. |
as cannabis use has become more common over the last decades, one would expect a related increase in the number of schizophrenia cases. |
2023-06-15 |
2023-08-14 |
Not clear |
| Gianfranco Di Gennaro, Marco Colizz. Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example. Epidemiology and psychiatric sciences. vol 32. 2023-06-15. PMID:37317558. |
by using such databases, we believe that the question whether changes in cannabis use are associated with changes in schizophrenia rates can be answered, at least partly. |
2023-06-15 |
2023-08-14 |
Not clear |
| Gianfranco Di Gennaro, Marco Colizz. Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example. Epidemiology and psychiatric sciences. vol 32. 2023-06-15. PMID:37317558. |
therefore, we tested these tools by evaluating trends in cannabis use and both cases and prevalence of schizophrenia in the united kingdom, one of the countries where the incident rates for psychotic disorder have been suggested to be particularly increased by cannabis consumption. |
2023-06-15 |
2023-08-14 |
Not clear |
| Laurent Elkrief, Bochao Lin, Mattia Marchi, Mohammad H Afzali, Tobias Banaschewski, Arun L W Bokde, Erin Burke Quinlan, Sylvane Desrivières, Herta Flor, Hugh Garavan, Penny Gowland, Andreas Heinz, Bernd Ittermann, Jean-Luc Martinot, Marie-Laure Paillère Martinot, Frauke Nees, Dimitri Papadopoulos Orfanos, Tomáš Paus, Luise Poustka, Sarah Hohmann, Juliane H Fröhner, Michael N Smolka, Henrik Walter, Robert Whelan, Gunter Schumann, Jurjen Luykx, Marco P Boks, Patricia J Conro. Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation. Psychological medicine. vol 53. issue 5. 2023-06-13. PMID:37310336. |
independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation. |
2023-06-13 |
2023-08-14 |
Not clear |
| Stephanie M Woolridge, Chelsea Wood-Ross, Rohit Voleti, Geoffrey W Harrison, Visar Berisha, Christopher R Bowi. A neuropsychological approach to differentiating cannabis-induced and primary psychotic disorders. Early intervention in psychiatry. vol 17. issue 6. 2023-06-06. PMID:37280059. |
rates of cannabis use are elevated in early psychosis populations, rendering it difficult to determine if an episode of psychosis is related to cannabis use (e.g., cannabis-induced psychosis), or if substance use is co-occurring with a primary psychotic disorder (e.g., schizophrenia). |
2023-06-06 |
2023-08-14 |
Not clear |
| Weiqiu Cheng, Nadine Parker, Naz Karadag, Elise Koch, Guy Hindley, Romain Icick, Alexey Shadrin, Kevin S O'Connell, Thomas Bjella, Shahram Bahrami, Zillur Rahman, Markos Tesfaye, Piotr Jaholkowski, Linn Rødevand, Børge Holen, Trine Vik Lagerberg, Nils Eiel Steen, Srdjan Djurovic, Anders M Dale, Oleksandr Frei, Olav B Smeland, Ole A Andreasse. The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study. The lancet. Psychiatry. vol 10. issue 6. 2023-05-19. PMID:37208114. |
we investigated the genetic association between psychotic disorders (schizophrenia and bipolar disorder) and cannabis phenotypes (lifetime cannabis use and cannabis use disorder). |
2023-05-19 |
2023-08-14 |
Not clear |